Monash research underpins Pfizer deal to develop cancer drugs

A multi-million dollar deal brokered between global pharmaceuticals giant Pfizer and Melbourne-based Cancer Therapeutics CRC (CTx) could lead to the development of life-saving cancer drugs, underpinned by Monash University research. CTx have announced a two-year research collaboration and a license agreement with Pfizer Inc worth $20 million upfront, but it could be worth as much […]